The decision, contained in a European Commission Delegated Regulation released this week amending Delegated Regulation (EU) ...

Researchers sought to determine whether combining enasidenib with venetoclax would be effective in patients with IDH2-mutated ...

Defendants say FinCEN’s AML reporting rule is authorized and necessary, countering Fidelity National’s legal challenge.

On December 31, 2025, the US Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN) finalized a two‑year ...

Hawk, the leading provider of AI-powered anti-money laundering, screening and fraud prevention solutions, today announced the ...

Revuforj® (revumenib) 4Q25 and full year 2025 net revenue, respectively – – Continued acceleration in demand following approval in R/R NPM1m AML, with an approximate 38% increase in Revuforj net ...

Belarus President Alexander Lukashenko has signed Decree No. 19, establishing a legal framework for bitcoin and crypto banks.

Detailed price information for Moleculin Biotech CS (MBRX-Q) from The Globe and Mail including charting and trades.

FinCEN has now adopted its previously‑proposed two‑year delay in the effective date for the investment adviser AML rule (including the requirements to establish AML programs and file SARs) until ...

Trenton, New Jersey, USA, January 15th, 2026, ChainwireHardware-Accelerated ZK Infrastructure Enables Private, ...

Ipsen (IPSEY) stock rises after the FDA offered Breakthrough Therapy Designation for its antibody therapy IPN60340 in acute myeloid leukemia. Read more here.